Patient-reported outcomes (PROs) in patients (pts) with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) primary advanced or recurrent endometrial cancer (pA/rEC) in the ENGOT-EN6-NSGO/GOG3031/RUBY trial-MedSci.cn

Patient-reported outcomes (PROs) in patients (pts) with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) primary advanced or recurrent endometrial cancer (pA/rEC) in the ENGOT-EN6-NSGO/GOG3031/RUBY trial

Valabrega, G; Powell, MA; Hietanen, S; Miller, EM; Novak, Z; Holloway, R; Denschlag, D; Myers, T; Thijs, AM; Pennington, K; Gilbert, L; Fleming, E; Copeland, L; Gogoi, R; Podzielinski, I; Cloven, N; Meyers, O; Garside, J; Mirza, MR; Black, D

ANNALS OF ONCOLOGY, 2023; 34 (): S513

科室
- - 订阅+
  - 更多科室
工具
服务